Tag - covid-19-vaccines



People wear masks at an evacuation center in the town of Anamizu, Ishikawa Prefecture, on Jan. 8. The number of people with acute respiratory infectious diseases, which include COVID-19 and influenza, at evacuation centers in the prefecture stood at 142 as of Sunday.
JAPAN / Science & Health
Jan 15, 2024
COVID and Japan, four years later: Normality, but words of caution
The nation has mostly returned to the pre-pandemic norm, but experts warn against people letting their guard down completely.
Demonstrators rally against COVID-19 vaccine mandates in Buffalo, New York, in February 2022.
Dec 26, 2023
It’s past time scientists admitted their COVID-19 mistakes
In 2019, 13% of Americans were distrustful enough to say they weren’t confident in scientists to act in the public’s best interest. Now it is 27%.
NHK headquarters in Tokyo's Shibuya Ward
JAPAN / Media
Dec 6, 2023
NHK found to have breached ethics with COVID vaccine news segment
A report in "News Watch 9" suggested three people lost family members to COVID-19 infection when they actually died after being vaccinated.
Prime Minister Fumio Kishida receives a COVID-19 booster shot in Tokyo on Nov. 11.
JAPAN / Science & Health
Nov 28, 2023
Japan approves first domestically developed COVID-19 XBB vaccine
The XBB-adapted coronavirus vaccine will be available as a booster under the nation’s free COVID-19 vaccination program beginning next week.
When COVID-19 first emerged, companies across the health care industry raced to reconfigure themselves. That transformation is now unraveling.
BUSINESS / Companies
Oct 18, 2023
Life after COVID turns rocky for reshaped health care businesses
When the coronavirus first emerged, companies across the health care industry raced to reconfigure themselves. That transformation is now unraveling.
Employees monitor the production of Covishield, the local name for the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, at the Serum Institute of India in Pune, Maharashtra, India.
BUSINESS / Companies
Oct 5, 2023
Top vaccine maker seeks growth by selling shots to globetrotters
Serum Institute of India plans to start production of yellow fever and dengue shots for travelers to countries where those diseases are endemic.
A new study defines some critical differences in certain biomarkers of people with long COVID.
Oct 4, 2023
Long COVID is real. Now the evidence is piling up.
In what the researchers believe is a first, they did a detailed study of the differences between people with long COVID and those who are healthy.
Katalin Kariko (right) and Drew Weissman, the winners of the 2023 Nobel Prize in physiology or medicine for their discoveries enabling the development of mRNA COVID-19 vaccines
Oct 3, 2023
Nobel for mRNA vaccines shows the power of perseverance
Decades of work by Nobel Prize winners Kariko and Weissman made the rapid development of COVID-19 mRNA vaccines possible.
A screen at the Karolinska Institute shows this year's laureates Katalin Kariko of Hungary (left) and Drew Weissman of the U.S. during the announcement of the winners of the Nobel Prize in physiology or medicine.
WORLD / Science & Health
Oct 2, 2023
Pair win medicine Nobel for work related to COVID-19 vaccines
Their findings "fundamentally changed our understanding of how mRNA interacts with our immune system," the Nobel committee said.
A vial of the Moderna COVID-19 booster vaccine targeting BA.4 and BA.5 omicron subvariants. Japan will roll out an updated version targeting the XBB variant on Wednesday.
JAPAN / Explainer
Sep 19, 2023
Japan to begin COVID vaccine drive targeting XBB subvariant
The free shots will be offered until March next year to prepare residents for an expected uptick in infections during the winter.
A man receives a COVID-19 vaccination  at Aoyama University in Tokyo in August 2021.
JAPAN / Science & Health
Sep 9, 2023
Japan to end free COVID-19 vaccinations in March
From fiscal 2024, the country will provide a COVID-19 shot once a year between to people aged 65 or over who are at high risk of severe symptoms.
One big challenge public health officials now face is how to restore trust so that people listen to future guidance on everything from flu shots to childhood vaccines.
Aug 27, 2023
Not all COVID-19 ‘misinformation’ is equal — nor misinformation
Public health scientists have to figure out how to get back to the kind of nuanced, thoughtful discussions that were the pre-pandemic norm.
Tourists walk along the road that leads to Kiyomizu Temple in Kyoto on Friday.
JAPAN / Science & Health
Aug 14, 2023
New coronavirus variant EG.5 gains momentum in Japan
The prevalence of EG.5, called Eris by health experts, nearly doubled in July to account for 22% of cases in Tokyo.
A health ministry panel has approved the messenger RNA vaccine Daichirona.
JAPAN / Science & Health
Aug 1, 2023
Japan panel endorses first domestically developed COVID vaccine
The shot is based on the original strain of the coronavirus, making it unlikely that it will be used in Japan or elsewhere.
Japan Times
Jul 6, 2023
Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market
The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as well as to produce them in China.
Japan Times
Jun 27, 2023
COVAX vaccine initiative has $2.6 billion left to spend as pandemic recedes
The initiative is set to wind up at the end of this year, although some of its work will continue.
Japan Times
JAPAN / Science & Health
Jun 19, 2023
Japan to roll out COVID-19 booster targeting XBB subvariant in the fall
A vaccine subcommittee under the health ministry is aiming to prepare for another spike in infections possibly arriving in the winter.
Japan Times
JAPAN / Science & Health
Jun 8, 2023
Japan seeing no COVID-19 resurgence a month after downgrade
Chief Cabinet Secretary Hirokazu Matsuno has said the number of cases is "rising moderately," however.
Japan Times
WORLD / Science & Health
May 24, 2023
COVID kills one person every four minutes as vaccine rates fall
After more than three years, the global health emergency is officially over. Much of the world is keen to move on, but vulnerable people and undervaccinated countries remain at risk.
Japan Times
JAPAN / Science & Health
May 19, 2023
Scientists urge G7 leaders to improve vaccine access in developing countries
Advocates used the summit to push back against the pharmaceutical industry’s pressure to strengthen intellectual property rights.


Hideo Shimoju points to a possible site that his fellow neighbors may relocate to. Such relocations have happened before, but not preemptively.
In disaster-prone Japan, some communities consider major moves